In last trading session, Marinus Pharmaceuticals Inc (NASDAQ:MRNS) saw 2.3 million shares changing hands with its beta currently measuring 1.11. Company’s recent per share price level of $1.47 trading at $0.06 or 4.26% at ring of the bell on the day assigns it a market valuation of $80.32M. That closing price of MRNS’s stock is at a discount of -665.99% from its 52-week high price of $11.26 and is indicating a premium of 24.49% from its 52-week low price of $1.11. Taking a look at company’s average trading volume volume of 1.83 million if we extend that period to 3-months.
Marinus Pharmaceuticals Inc (NASDAQ:MRNS) trade information
Upright in the green during last session for gaining 4.26%, in the last five days MRNS remained trading in the green while hitting it’s week-highest on Wednesday, 05/01/24 when the stock touched $1.47 price level, adding 3.29% to its value on the day. Marinus Pharmaceuticals Inc’s shares saw a change of -86.48% in year-to-date performance and have moved 2.08% in past 5-day. Marinus Pharmaceuticals Inc (NASDAQ:MRNS) showed a performance of -83.43% in past 30-days.
Marinus Pharmaceuticals Inc (MRNS) estimates and forecasts
Statistics highlight that Marinus Pharmaceuticals Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -79.00% of value to its shares in past 6 months, showing an annual growth rate of 15.21% while that of industry is 11.40. Apart from that, the company came raising its revenue forecast for fiscal year 2024.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 6.04% during past 5 years. In 2024, company’s earnings growth rate is likely to be around 16.53% while estimates for its earnings growth in next 5 years are of 20.00%.
MRNS Dividends
Marinus Pharmaceuticals Inc is more likely to be releasing its next quarterly report in June and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
